{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:44:41Z","timestamp":1793727881893,"version":"4.6.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Gabapentin is commonly prescribed for the treatment of neuropathic pain, restless leg syndrome, and partial-onset seizures. Although the most frequent side effects of gabapentin are associated with the central nervous system, gabapentin can also affect the cardiovascular system. Case reports and observational studies have showed that gabapentin can be associated with increased risk of atrial fibrillation. However, all the evidence is concentrated in patients older than 65\u00a0years old with comorbidities that predispose them to the development of arrhythmias.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>We describe a case of an African American male in his 20s that presented to our chronic pain clinic with lumbar radiculitis and developed atrial fibrillation 4\u00a0days after being started on gabapentin. Laboratory workup did not show significant abnormalities, including normal complete blood count, comprehensive metabolic panel, toxicology screen, and thyroid-stimulating hormone. Transthoracic and transesophageal echocardiography showed a patent foramen ovale with right-to-left shunt. The patient was initially treated with diltiazem for heart rate control and apixaban. Direct current cardioversion with successful conversion to sinus rhythm was performed 24\u00a0hours after admission. The patient was then discharged on apixaban and diltiazem. Apixaban was changed to low-dose aspirin 1\u00a0month after discharge.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>With rapidly increasing usage of gabapentin for approved and off-label indications, it is important to identify unintended adverse effects of this drug as they are considered safe alternatives to opioids. New-onset atrial fibrillation could be induced by gabapentin in young individuals.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13256-023-03975-1","type":"journal-article","created":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:01:50Z","timestamp":1686268910000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Atrial fibrillation induced by gabapentin: a case report"],"prefix":"10.1186","volume":"17","author":[{"given":"Sung Hwan","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4220-4979","authenticated-orcid":false,"given":"Yuri Chaves","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,9]]},"reference":[{"issue":"5","key":"3975_CR1","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMp1704633","volume":"377","author":"CW Goodman","year":"2017","unstructured":"Goodman CW, Brett AS. Gabapentin and pregabalin for pain\u2014is increased prescribing a cause for concern? N Engl J Med. 2017;377(5):411\u20134.","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"3975_CR2","first-page":"S89","volume":"61","author":"KE Evoy","year":"2021","unstructured":"Evoy KE, Peckham AM, Covvey JR, Tidgewell KJ. Gabapentinoid pharmacology in the context of emerging misuse liability. J Clin Pharmacol. 2021;61(Suppl 2):S89\u201399.","journal-title":"J Clin Pharmacol"},{"issue":"9","key":"3975_CR3","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/pds.5036","volume":"29","author":"BN Harding","year":"2020","unstructured":"Harding BN, Wiggins KL, Jensen PN, McKnight B, Psaty BM, Heckbert SR, et\u00a0al. Opioid, gabapentinoid, and nonsteroidal anti-inflammatory medication use and the risks of atrial fibrillation and supraventricular ectopy in the Multi-Ethnic Study of Atherosclerosis. Pharmacoepidemiol Drug Saf. 2020;29(9):1175\u201382.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"3975_CR4","first-page":"644","volume":"44","author":"KB Tellor","year":"2019","unstructured":"Tellor KB, Ngo-Lam R, Badran D, Armbruster AL, Schwarze MW. A rare case of a gabapentin-induced cardiomyopathy. J Clin Pharm Ther. 2019;44(4):644\u20136.","journal-title":"J Clin Pharm Ther"},{"issue":"12","key":"3975_CR5","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s40264-018-0695-6","volume":"41","author":"L Ortiz de Landaluce","year":"2018","unstructured":"Ortiz de Landaluce L, Carbonell P, Asensio C, Escoda N, Lopez P, Laporte JR. Gabapentin and pregabalin and risk of atrial fibrillation in the elderly: a population-based cohort study in an electronic prescription database. Drug Saf. 2018;41(12):1325\u201331.","journal-title":"Drug Saf."},{"key":"3975_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fcvm.2020.00003","volume":"7","author":"M Kavousi","year":"2020","unstructured":"Kavousi M. Differences in epidemiology and risk factors for atrial fibrillation between women and men. Front Cardiovasc Med. 2020;7:3.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"3975_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1161\/CIRCRESAHA.120.316340","volume":"127","author":"J Kornej","year":"2020","unstructured":"Kornej J, Borschel CS, Benjamin EJ, Schnabel RB. Epidemiology of atrial fibrillation in the 21st century: novel methods and new insights. Circ Res. 2020;127(1):4\u201320.","journal-title":"Circ Res"},{"issue":"22","key":"3975_CR8","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","volume":"322","author":"D Levy","year":"1990","unstructured":"Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322(22):1561\u20136.","journal-title":"N Engl J Med"},{"issue":"9","key":"3975_CR9","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.117.309732","volume":"120","author":"L Staerk","year":"2017","unstructured":"Staerk L, Sherer JA, Ko D, Benjamin EJ, Helm RH. Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes. Circ Res. 2017;120(9):1501\u201317.","journal-title":"Circ Res"},{"key":"3975_CR10","volume":"35","author":"SG Wannamethee","year":"2021","unstructured":"Wannamethee SG, Papacosta O, Lennon L, Hingorani A, Whincup P. Adult height and incidence of atrial fibrillation and heart failure in older men: the British Regional Heart Study. Int J Cardiol Heart Vasc. 2021;35: 100835.","journal-title":"Int J Cardiol Heart Vasc"},{"key":"3975_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.639993","volume":"8","author":"H Xiang","year":"2021","unstructured":"Xiang H, Xue Y, Chen Z, Yu Y, Peng Y, Wang J, et\u00a0al. The association between left ventricular hypertrophy and the occurrence and prognosis of atrial fibrillation: a meta-analysis. Front Cardiovasc Med. 2021;8: 639993.","journal-title":"Front Cardiovasc Med"},{"issue":"7","key":"3975_CR12","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/sms.13416","volume":"29","author":"C Cuspidi","year":"2019","unstructured":"Cuspidi C, Sala C, Tadic M, Baccanelli G, Gherbesi E, Grassi G, et\u00a0al. Left atrial volume in elite athletes: a meta-analysis of echocardiographic studies. Scand J Med Sci Sports. 2019;29(7):922\u201332.","journal-title":"Scand J Med Sci Sports"},{"issue":"23","key":"3975_CR13","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1136\/heartjnl-2012-303465","volume":"99","author":"V Utomi","year":"2013","unstructured":"Utomi V, Oxborough D, Whyte GP, Somauroo J, Sharma S, Shave R, et\u00a0al. Systematic review and meta-analysis of training mode, imaging modality and body size influences on the morphology and function of the male athlete\u2019s heart. Heart. 2013;99(23):1727\u201333.","journal-title":"Heart"},{"issue":"Suppl 1","key":"3975_CR14","first-page":"S115","volume":"8","author":"G Chilkoti","year":"2014","unstructured":"Chilkoti G, Wadhwa R, Saxena A, Khurana P. Could pregabalin premedication predispose to perioperative atrial fibrillation in patients with sepsis? Saudi J Anaesth. 2014;8(Suppl 1):S115\u20136.","journal-title":"Saudi J Anaesth"},{"key":"3975_CR15","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2147\/JPR.S63028","volume":"7","author":"K Onouchi","year":"2014","unstructured":"Onouchi K, Koga H, Yokoyama K, Yoshiyama T. An open-label, long-term study examining the safety and tolerability of pregabalin in Japanese patients with central neuropathic pain. J Pain Res. 2014;7:439\u201347.","journal-title":"J Pain Res"},{"issue":"2","key":"3975_CR16","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.revmed.2007.07.009","volume":"29","author":"MA Laville","year":"2008","unstructured":"Laville MA, de la Gastine B, Husson B, Le Boisselier R, Mosquet B, Coquerel A. Should we care about pregabalin for elderly patients with a history of cardiac dysrhythmia? Rev Med Interne. 2008;29(2):152\u20134.","journal-title":"Rev Med Interne"},{"key":"3975_CR17","unstructured":"Martinez L, Therasse C, Ginisty S, Eftekhari P. Cardiac events and pregabalin: spontaneous reports notifed to the French pharmacovigilance database. 34\u00e8mes Journ\u00e9es de Pharmacovigilance, Angers, 22\u201324 April 2013. Fundamental Clin Pharmacol. 2013;27:1."}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-023-03975-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-023-03975-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-023-03975-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T21:33:04Z","timestamp":1702589584000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-023-03975-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,9]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3975"],"URL":"https:\/\/doi.org\/10.1186\/s13256-023-03975-1","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,9]]},"assertion":[{"value":"13 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Saint Louis University institutional review board was consulted and the need for approval was waived. Guidelines for case reports published by Saint Louis University institutional review board can be found at.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"236"}}